DACHAUNDA PETE: Open Payments
NPI 1326684903 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$108 in 6 payments from 4 companies in 2025. Trend: 2023 $130 · 2024 $209 · 2025 $108
Food & beverage: $108
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: ABILIFY MAINTENA, UZEDY, LYBALVI, INVEGA SUSTENNA, ARISTADA.
Industry payments across OK — which companies pay providers there.
